KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Free Cash Flow: 2017-2025

Historic Free Cash Flow for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to -$24.2 million.

  • Twist Bioscience's Free Cash Flow fell 39.94% to -$24.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$75.6 million, marking a year-over-year decrease of 9.34%. This contributed to the annual value of -$75.6 million for FY2025, which is 9.34% down from last year.
  • Latest data reveals that Twist Bioscience reported Free Cash Flow of -$24.2 million as of Q3 2025, which was down 129.45% from -$10.6 million recorded in Q2 2025.
  • Twist Bioscience's 5-year Free Cash Flow high stood at -$7.3 million for Q2 2024, and its period low was -$74.8 million during Q2 2022.
  • Moreover, its 3-year median value for Free Cash Flow was -$23.1 million (2023), whereas its average is -$22.7 million.
  • Per our database at Business Quant, Twist Bioscience's Free Cash Flow slumped by 125.52% in 2022 and then skyrocketed by 73.70% in 2024.
  • Twist Bioscience's Free Cash Flow (Quarterly) stood at -$59.4 million in 2021, then declined by 10.87% to -$65.9 million in 2022, then surged by 62.85% to -$24.5 million in 2023, then grew by 3.20% to -$23.7 million in 2024, then crashed by 39.94% to -$24.2 million in 2025.
  • Its last three reported values are -$24.2 million in Q3 2025, -$10.6 million for Q2 2025, and -$17.1 million during Q1 2025.